Sign Up Today and Learn More About Matchpoint Therapeutics Stock
Invest in or calculate the value of your shares in Matchpoint Therapeutics or other pre-IPO companies through EquityZen's platform.
Matchpoint Therapeutics Stock (MATH)
Matchpoint Therapeutics is a biotechnology company that integrates chemoproteomics, ML, and covalent chemistry to treat serious illnesses.
About Matchpoint Therapeutics Stock
Founded
2021
Headquarters
Cambridge, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Matchpoint Therapeutics Press Mentions
Stay in the know about the latest news on Matchpoint Therapeutics
Diazepino-thieno-quinoxaline compounds and their use in therapy
patents • Apr 13, 2024
Matchpoint Therapeutics Raises $100M in Series A and Seed Funding
finsmes • Oct 18, 2022
Matchpoint Therapeutics Launches to Develop Covalent Medicines
ow • Oct 16, 2022
The Week’s 10 Biggest Funding Rounds: Odyssey’s Epic Round, Uniswap Raises Big And Mini Golf Gets Cash
news • Oct 14, 2022
Matchpoint Therapeutics Management
Leadership team at Matchpoint Therapeutics
Board Member
Dan Becker
Board Member
Andre Turenne
Join now and verify your accreditation status to gain access to:
- Matchpoint Therapeutics current valuation
- Matchpoint Therapeutics stock price
- Available deals in Matchpoint Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Matchpoint Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Matchpoint Therapeutics through EquityZen funds. These investments are made available by existing Matchpoint Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Matchpoint Therapeutics stock?
Shareholders can sell their Matchpoint Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
